These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3814764)

  • 1. Studies on serum mucoproteins in patients with urinary calculi.
    Rahman MA; Rahman B; Perveen S
    Biomed Pharmacother; 1986; 40(8):311-3. PubMed ID: 3814764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the presence of abnormal proteins in the urine of recurrent stone formers.
    Grover PK; Resnick MI
    J Urol; 1995 May; 153(5):1716-21. PubMed ID: 7715017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects.
    Wikström B; Backman U; Danielson BG; Fellström B; Hellsing K; Johansson G; Ljunghall S
    Scand J Urol Nephrol Suppl; 1981; 61():I:1-18. PubMed ID: 6947410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of magnesium intake to serum and urinary calcium and magnesium levels in Trinidadian stone formers.
    Anatol TI; Pinto Pereira L; Matthew J; Sawh L
    Int J Urol; 2005 Mar; 12(3):244-9. PubMed ID: 15828950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of mucoproteins & glycoproteins in normal & stone forming bovines.
    Singh K; Gera KL; Nandan D; Nigam JM
    Indian J Exp Biol; 1980 Jun; 18(6):651-2. PubMed ID: 7439953
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of urinary stone in children from north-eastern Thailand.
    Aegukkatajit S
    J Med Assoc Thai; 1999 Dec; 82(12):1230-3. PubMed ID: 10659566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of proteins in urinary tract stones and urine of urolithic patients].
    Yokomizoi K; Nakayama A; Hokazono E; Ninomiya A; Miyake R; Hiratsuka N; Okuyama M; Kato Y; Kobayashi S; Ito Y; Shiba K
    Rinsho Byori; 2005 Dec; 53(12):1109-15. PubMed ID: 16447682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of genetic factors on family history of upper urinary stones].
    Ishikawa Y; Konya E; Yamate T; Amasaki N; Umekawa T; Katayama Y; Takamura C; Takada M; Kajikawa H; Katoh Y
    Hinyokika Kiyo; 1995 May; 41(5):349-53. PubMed ID: 7598034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury.
    Donnellan SM; Bolton DM
    BJU Int; 1999 Aug; 84(3):280-5. PubMed ID: 10468722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and risk factors for calculi formation in patients treated with augmentation cystoplasty or intestinal substitution].
    López Cubillana P; Gómez Gómez G; Ruiz Gómez JM; Prieto González A; Asensio Egea LJ; Rigabert Montiel M; Nicolás Torralba JA; Bañón Pérez V; Server Pastor G; Pérez Albacete M
    Arch Esp Urol; 1998 May; 51(4):347-52. PubMed ID: 9656556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased acid excretion in kidney stone formers with essential hypertension.
    Losito A; Nunzi EG; Covarelli C; Nunzi E; Ferrara G
    Nephrol Dial Transplant; 2009 Jan; 24(1):137-41. PubMed ID: 18715964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional modification of THP on nitration: comparison with stone formers THP.
    Pragasam V; Kalaiselvi P; Subashini B; Sumitra K; Varalakshmi P
    Nephron Physiol; 2005; 99(1):p28-34. PubMed ID: 15637470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.